Michael Gwarisa In a move aimed at strengthening collaboration to advance health security, workforce development, and resilient public health systems across Africa, the Africa Centres for Disease Control and Prevention has signed a Memorandum of Understanding (MoU) with FHI 360. The MoU sets in motion a structured framework for cooperation aligned with Africa CDC’s Strategic
Read More
Michael Gwarisa Zimbabwe has set the stage for the rollout of Lenacapavir, a long acting injectable HIV prevention medicine that is expected to significantly strengthen the country’s HIV response. The injectable drug, which is administered only twice a year, is being introduced as part of Zimbabwe’s expanded HIV prevention strategy targeting people at high risk
Read More
Kuda Pembere Zimbabwe has begun the process of drafting its new National Health Strategy which also aimes to ensure all health financing is properly managed and effectively utilized, a top Cabinet official has said. This includes the much-anticipated National Health Insurance Scheme (NHIS), which is set to provide financial protection for families and reduce out-of-pocket
Read More
Kuda Pembere Zimbabwe has begun developing the National Health Strategy (2026–2030), which will guide the country’s health sector reforms through to the end of the decade. Aligned with the National Development Strategy 2 (NDS2), the plan focuses on reducing maternal and under-five mortality, strengthening primary health care, and expanding access to essential services. According to
Read More
Michael Gwarisa African Heads of State and Government have pledged to accelerate local manufacturing of health products as part of a continent wide push to strengthen health security, reduce import dependence, and improve preparedness for future pandemics. Leaders from all 54 member states of the African Union made the commitment during high level engagements held
Read More
Michael Gwarisa Following weeks of anticipation, the Zimbabwean government has finally announced the dates for the rollout of lenacapavir, an injectable pre-exposure prophylaxis drug. The rollout had initially been scheduled for January 2026. According to The Herald, the Permanent Secretary in the Ministry of Health and Child Care, Dr Aspect Maunganidze, confirmed that the drug
Read More
By Michael Gwarisa The Democratic Republic of Congo (DRC) accounts for 68 percent of all cholera cases reported in the region in 2026, as well as 80 percent of all cholera-related deaths, the Africa Centres for Disease Control and Prevention (Africa CDC) has said. Other African countries currently experiencing active cholera outbreaks include Zimbabwe, Zambia,
Read More
Click here By Kudakwashe Pembere Working in the diaspora is many a Zimbabwean’s dream, drawn by the promise of better salaries. When an opportunity for English teachers to work in the Orient arose, Rachael Musekiwa grabbed it and off she went. Months later, she returned home battling Stage Five kidney failure and facing a US
Read More
By Michael Gwarisa As Zimbabwe prepares to roll out Lenacapavir, an injectable pre-exposure prophylaxis drug, anticipation is growing among people waiting for their turn. The initial consignment consists of just 2,000 doses, meaning distribution will focus on groups classified as high risk. Despite its high efficacy, Dr Owen Mugurungi, Director of AIDS, TB and Malaria
Read More
By Kuda Pembere With debate on Clause 11 of the Medical Services Amendment Bill, which deals with termination of pregnancy or abortion as well as other issues, expected to top the Senate’s business this year, the Upper House on Tuesday skipped the Bill’s debate. The debate was deferred due to the absence of the Health
Read More